The results demonstrated that PLAUR expression was significantly positively correlated with CD274, CTLA4, HAVCR2, LAG3, PDCD1, PDCD1LG2, and TIGIT, indicating that targeting PLAUR might increase the efficacy of immunotherapy in NSCLC. This evidence concerns the gene HAVCR2 and non-small cell lung carcinoma.